1. Home
  2. NVAX vs NTST Comparison

NVAX vs NTST Comparison

Compare NVAX & NTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NTST
  • Stock Information
  • Founded
  • NVAX 1987
  • NTST 2019
  • Country
  • NVAX United States
  • NTST United States
  • Employees
  • NVAX N/A
  • NTST N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NTST Real Estate Investment Trusts
  • Sector
  • NVAX Health Care
  • NTST Real Estate
  • Exchange
  • NVAX Nasdaq
  • NTST Nasdaq
  • Market Cap
  • NVAX 1.3B
  • NTST 1.3B
  • IPO Year
  • NVAX 1995
  • NTST 2020
  • Fundamental
  • Price
  • NVAX $6.56
  • NTST $18.30
  • Analyst Decision
  • NVAX Buy
  • NTST Strong Buy
  • Analyst Count
  • NVAX 6
  • NTST 10
  • Target Price
  • NVAX $15.33
  • NTST $18.53
  • AVG Volume (30 Days)
  • NVAX 5.1M
  • NTST 1.7M
  • Earning Date
  • NVAX 08-06-2025
  • NTST 07-23-2025
  • Dividend Yield
  • NVAX N/A
  • NTST 4.70%
  • EPS Growth
  • NVAX N/A
  • NTST N/A
  • EPS
  • NVAX 2.97
  • NTST N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • NTST $179,740,000.00
  • Revenue This Year
  • NVAX $52.02
  • NTST $12.97
  • Revenue Next Year
  • NVAX N/A
  • NTST $6.22
  • P/E Ratio
  • NVAX $2.21
  • NTST N/A
  • Revenue Growth
  • NVAX 25.92
  • NTST 21.39
  • 52 Week Low
  • NVAX $5.01
  • NTST $13.42
  • 52 Week High
  • NVAX $15.22
  • NTST $18.93
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 40.82
  • NTST 65.23
  • Support Level
  • NVAX $6.93
  • NTST $18.17
  • Resistance Level
  • NVAX $8.46
  • NTST $18.80
  • Average True Range (ATR)
  • NVAX 0.34
  • NTST 0.43
  • MACD
  • NVAX -0.08
  • NTST 0.02
  • Stochastic Oscillator
  • NVAX 9.52
  • NTST 62.58

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

Share on Social Networks: